We have previously developed a molecular imaging agent that specifically binds to the PTPμ extracellular fragment, called SBK2 that is linked to a fluorophore, and labels both the main GBM tumor mass [5] and greater than 99% of the dispersing cells up to 3.5 mm away from the main tumor [7]. Here, SBK2 is linked to neoplasm.